Submitted by Anonymous (not verified) on 2 March 2026 - 16:02
Human medicines European public assessment report (EPAR): Lamzede, velmanase alfa, Date of authorisation: 23/03/2018, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lamzede, velmanase alfa, Date of authorisation: 23/03/2018, Revision: 7, Status: Authorised